Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.39 |
| ▸ | TACR3 | P29371 | 8/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.35 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14282971 | 0.90 | CTSB (0.40) | KDM4EALDH1A1SMN1; SMN2ADAM17TACR3 | |
| SCHEMBL14282972 | 0.90 | CTSB (0.40) | KDM4EALDH1A1SMN1; SMN2ADAM17TACR3 | |
| SCHEMBL12325204 | 0.87 | ADAM17 (0.37) | KDM4EALDH1A1SMN1; SMN2ADAM17TACR3 | |
| SCHEMBL7945558 | 0.86 | MCL1 (0.40) | KDM4EALDH1A1SMN1; SMN2TACR3CTSB | |
| SCHEMBL5692638 | 0.86 | MCL1 (0.40) | KDM4EALDH1A1SMN1; SMN2TACR3CTSB | |
| SCHEMBL5692554 | 0.86 | KDM4E (0.39) | KDM4EALDH1A1SMN1; SMN2TACR3CTSB | |
| SCHEMBL4979076 | 0.85 | CTSB (0.41) | KDM4EALDH1A1SMN1; SMN2ADAM17TACR3 | |
| SCHEMBL5692743 | 0.84 | MCL1 (0.40) | KDM4EALDH1A1SMN1; SMN2TACR3CTSB | |
| SCHEMBL14307115 | 0.84 | MCL1 (0.40) | KDM4EALDH1A1SMN1; SMN2TACR3CTSB | |
| SCHEMBL12325022 | 0.84 | MCL1 (0.39) | KDM4EALDH1A1SMN1; SMN2ADAM17TACR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7323447-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-01-29 | — | — | US | disclosed |